CTNNB1 and hepatocellular carcinoma: To investigate this, we initially selected two HCC cell lines: HUH6, which harbors G34V somatic activating mutation in CTNBB1/β-catenin, and SNU387, which is CTNNB1/β-catenin wild-type and has low levels of active β-catenin protein.